Category: Publications in Scholarly Journals

With Allison Schlosser, Roma Subramanian, Ciera E. Kirkpatrick, Annie Butler, Jessica Hample, Patrick Habecker, Valerie Jones. Algorithmic doors to community and the trap of visibility: TikTok for harm reduction activism in the U.S. overdose crisis. Contemporary Drug Problems. May 6, 2024.

With Jason R. Bush, Jun Han et al. Resistant potato starch supplementation reduces serum histamine levels in healthy adults with links to attenuated intestinal permeability. Journal of Functional Foods. September 1, 2023.

With Julia Montenegro, Anissa M. Armet et al. Exploring the influence of gut microbiome on energy metabolism in humans. Advances in Nutrition. July 1, 2023.

With Xin Zong, Hao Zhang et al. Auricularia auricula polysaccharides attenuate obesity in mice through gut commensal Papillibacter cinnamivorans. Journal of Advanced Research. October 1, 2023.

With J.J. Velez, H. Botkin et al. One without the other: Contextualizing mobility through discourse analysis. Journal of Agricultural Education. June 30, 2024.

With L.L. Rada, A.R. Smith. Measuring mobility: A quantitative description of mobility in Minnesota. Journal of Agricultural Education. March 31, 2024.

With M.R. Barnes, I.A. Campagna, E. Watkins. Unearthing green potential: Assessing the state of managed urban landscape curricula in Minnesota’s higher education institutions. Natural Sciences Education. February 27, 2024.

With J.J. Velez, H. Botkin et al. That’s not in my position description: A discourse analysis of SBAE migratory context. Journal of Agricultural Education. October 1, 2023.

With Zhengxiao Zhang, Nguyen K. Nguyen et al. Adaptation to tolerate high doses of arabinoxylan is associated with fecal levels of Bifidobacterium longum. Gut Microbes. June 11, 2024.

With Zhengxiao Zhang, Valentin Mocanu et al. Recipient microbiome-related features predicting metabolic improvement following fecal microbiota transplantation in adults with severe obesity and metabolic syndrome: A secondary analysis of a phase 2 clinical trial. Gut Microbes. April 29, 2024.